Journal of Critical Care
Volume 22, Issue 1 , Pages 1-12 , March 2007

Hemofiltration in sepsis and systemic inflammatory response syndrome: The role of dosing and timing

  • Catherine S.C. Bouman, MD

      Affiliations

    • Department of Intensive Care, Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 20 5662509.
    • ,
  • Heleen M. Oudemans-van Straaten, MD, PhD

      Affiliations

    • Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, 1100 DD Amsterdam, The Netherlands
    • ,
  • Marcus J. Schultz, MD, PhD

      Affiliations

    • Department of Intensive Care, Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands
    • Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, PO 95500, 1090 HM Amsterdam, The Netherlands
    • ,
  • Margreeth B. Vroom, MD, PhD

      Affiliations

    • Department of Intensive Care, Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands

References 

  1. Bellomo R, Ronco C. Continuous renal replacement therapy: continuous blood purification in the intensive care unit. Ann Acad Med Singapore. 1998;27:426–429
  2. Gotloib L, Barzilay E, Shustak A, et al. Sequential hemofiltration in nonoliguric high capillary permeability pulmonary edema of severe sepsis: preliminary report. Crit Care Med. 1984;12:997–1000
  3. De Vriese AS, Colardyn FA, Philippe JJ, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999;10:846–853
  4. Bone RC. Important new findings in sepsis. JAMA. 1997;278:249
  5. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–150
  6. Ronco C, Ricci Z, Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous haemofiltration. Curr Opin Nephrol Hypertens. 2001;10:755–761
  7. Reiter K, Bellomo R, Ronco C, et al. Pro/con clinical debate: is high-volume hemofiltration beneficial in the treatment of septic shock?. Crit Care. 2002;6:18–21
  8. Bellomo R, Honore PM, Matson J, et al. Extracorporeal blood treatment (EBT) methods in SIRS/sepsis. Int J Artif Organs. 2005;28:450–458
  9. De Vriese AS, Vanholder RC, Pascual M, et al. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?. Intensive Care Med. 1999;25:903–910
  10. Venkataraman R, Kellum JA, Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States. J Crit Care. 2002;17:246–250
  11. Grootendorst AF, van Bommel EF, van der Hoven B, et al. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med. 1992;18:235–240
  12. Lee PA, Weger GW, Pryor RW, et al. Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus–induced septicemia in immature swine. Crit Care Med. 1998;26:730–737
  13. Rogiers P, Zhang H, Pauwels D, et al. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock. Crit Care Med. 2003;31:1219–1225
  14. Yekebas EF, Strate T, Zolmajd S, et al. Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int. 2002;62:1806–1818
  15. Brunet S, Leblanc M, Geadah D, et al. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis. 1999;34:486–492
  16. Kellum JA, Johnson JP, Kramer D, et al. Diffusive versus convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med. 1998;26:1995–2000
  17. Bouman CS, van Olden RW, Stoutenbeek CP. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif. 1998;16:261–268
  18. Clark WR, Hamburger RJ, Lysaght MJ. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Kidney Int. 1999;56:2005–2015
  19. Clark WR, Gao D. Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol. 2002;13(Suppl 1):S41–S47
  20. Morgera S. Management of acute renal failure with high permeability haemofiltration in sepsis: practical aspects. Int J Intensive Care. 2006;139–145
  21. Mariano F, Tetta C, Guida G, et al. Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Kidney Int. 2001;60:1598–1605
  22. Morgera S, Haase M, Rocktaschel J, et al. High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure. Nephrol Dial Transplant. 2003;18:2570–2576
  23. Morgera S, Klonower D, Rocktaschel J, et al. TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients?. Nephrol Dial Transplant. 2003;18:1361–1369
  24. Morgera S, Slowinski T, Melzer C, et al. Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis. 2004;43:444–453
  25. Uchino S, Bellomo R, Morimatsu H, et al. Cytokine dialysis: an ex vivo study. ASAIO J. 2002;48:650–653
  26. Kellum JA, Dishart MK. Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats. Crit Care. 2002;6:429–433
  27. van Bommel EF, Hesse CJ, Jutte NH, et al. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. Ren Fail. 1997;19:443–454
  28. Schulman G. A review of the concept of biocompatibility. Kidney Int Suppl. 1993;41:S209–S212
  29. Gomez A, Wang R, Unruh H, et al. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology. 1990;73:671–685
  30. Mink SN, Jha P, Wang R, et al. Effect of continuous arteriovenous hemofiltration combined with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology. 1995;83:178–190
  31. DiScipio AW, Burchard KW. Continuous arteriovenous hemofiltration attenuates polymorphonuclear leukocyte phagocytosis in porcine intra-abdominal sepsis. Am J Surg. 1997;173:174–180
  32. Stein B, Pfenninger E, Grunert A, et al. Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med. 1990;16:494–499
  33. Stein B, Pfenninger E, Grunert A, et al. The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model. Intensive Care Med. 1991;17:293–298
  34. Cole L, Bellomo R, Hart G, et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med. 2002;30:100–106
  35. John S, Griesbach D, Baumgartel M, et al. Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant. 2001;16:320–327
  36. Phu NH, Hien TT, Mai NT, et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med. 2002;347:895–902
  37. Sander A, Armbruster W, Sander B, et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med. 1997;23:878–884
  38. Heering P, Morgera S, Schmitz FJ, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med. 1997;23:288–296
  39. Hoffmann JN, Hartl WH, Deppisch R, et al. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med. 1996;22:1360–1367
  40. Klouche K, Cavadore P, Portales P, et al. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations. J Nephrol. 2002;15:150–157
  41. Kruger I, Jacobi C, Landwehr P. Effects of continuous venovenous hemofiltration on pulmonary function and hemodynamics in postoperative septic multiorgan failure. Contrib Nephrol. 1995;116:108–111
  42. Level C, Chauveau P, Guisset O, et al. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit Care. 2003;7:R160–R166
  43. Meloni C, Morosetti M, Turani F, et al. Cardiac function and oxygen balance in septic patients during continuous hemofiltration. Blood Purif. 1998;16:140–146
  44. Ossenkoppele GJ, van der MJ, Bronsveld W, Thijs LG. Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock. Crit Care Med. 1985;13:102–104
  45. Blinzler L, Hausser J, Bodeker H, et al. Conservative treatment of severe necrotizing pancreatitis using early continuous venovenous hemofiltration. Contrib Nephrol. 1991;93:234–236
  46. Cosentino F, Paganini F, Lockrem J, et al. Continuous arteriovenous hemofiltration in the adult respiratory distress syndrome. Contrib Nephrol. 1991;93:94–97
  47. Gotloib L, Barzilay E, Shustak A, et al. Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation. 1986;13:123–132
  48. Matamis D, Tsagourias M, Koletsos K, et al. Influence of continuous haemofiltration-related hypothermia on haemodynamic variables and gas exchange in septic patients. Intensive Care Med. 1994;20:431–436
  49. Heidemann SM, Ofenstein JP, Sarnaik AP. Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock. 1994;44:183–187
  50. Murphey ED, Fessler JF, Bottoms GD, et al. Effects of continuous venovenous hemofiltration on cardiopulmonary function in a porcine model of endotoxin-induced shock. Am J Vet Res. 1997;58:408–413
  51. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356:26–30
  52. Lee PA, Matson JR, Pryor RW, et al. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus–induced septicemia in immature swine. Crit Care Med. 1993;21:914–924
  53. Ullrich R, Roeder G, Lorber C, et al. Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology. 2001;95:428–436
  54. Bellomo R, Kellum JA, Gandhi CR, et al. The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med. 2000;161:1429–1436
  55. Rogiers P, Zhang H, Smail N, et al. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med. 1999;27:1848–1855
  56. Grootendorst AF, van Bommel EF, van Leengoed LA, et al. Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care. 1993;8:161–169
  57. Grootendorst AF, van Bommel EF, van Leengoed LA, et al. High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock. 1994;2:72–78
  58. Wang H, Zhang ZH, Yan XW, et al. Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis. World J Gastroenterol. 2005;11:127–131
  59. Yekebas EF, Eisenberger CF, Ohnesorge H, et al. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med. 2001;29:1423–1430
  60. Freeman BD, Yatsiv I, Natanson C, et al. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg. 1995;180:286–292
  61. Cole L, Bellomo R, Journois D, et al. High-volume haemofiltration in human septic shock. Intensive Care Med. 2001;27:978–986
  62. Jiang HL, Xue WJ, Li DQ, et al. Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol. 2005;11:4815–4821
  63. Laurent I, Adrie C, Vinsonneau C, et al. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol. 2005;46:432–437
  64. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a “sepsis-like” syndrome. Circulation. 2002;106:562–568
  65. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med. 2000;28:3581–3587
  66. Joannes-Boyau O, Rapaport S, Bazin R, et al. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J. 2004;50:102–109
  67. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, et al. Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med. 1999;25:814–821
  68. Ratanarat R, Brendolan A, Piccinni P, et al. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care. 2005;9:R294–R302
  69. Wang H, Li WQ, Zhou W, et al. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol. 2003;9:2096–2099
  70. Honore PM, Matson JR. Short-term high-volume hemofiltration in sepsis: perhaps the right way is to start with. Crit Care Med. 2002;30:1673–1674
  71. Mink SN, Li X, Bose D, et al. Early but not delayed continuous arteriovenous hemofiltration improves cardiovascular function in sepsis in dogs. Intensive Care Med. 1999;25:733–743
  72. Yekebas EF, Treede H, Knoefel WT, et al. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg. 1999;229:514–522
  73. Veenman JN, Dujardint CL, Hoek A, et al. High volume continuous venovenous haemofiltration (HV-CVVH) in an equine endotoxaemic shock model. Equine Vet J. 2002;34:516–522
  74. Morgera S, Rocktaschel J, Haase M, et al. Intermittent high permeability hemofiltration in septic patients with acute renal failure. Intensive Care Med. 2003;29:1989–1995
  75. Uchino S, Bellomo R, Goldsmith D, et al. Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med. 2002;28:651–655

☆ CSCB performed the search, analyzed the data, and drafted the manuscript. HMO-vS contributed to the search. HMO-vS, MJS, and MBV critically reviewed the manuscript.

PII: S0883-9441(06)00083-9

doi: 10.1016/j.jcrc.2006.05.002

Journal of Critical Care
Volume 22, Issue 1 , Pages 1-12 , March 2007

Article Tools